ANI Pharma Inc Purchase Agreements
12 Contracts & Agreements
- Amendment to Purchase and Sale Agreement between ANI Pharmaceuticals Canada Inc. and Mastercom Inc (Filed With SEC on February 29, 2024)
- Purchase and Sale Agreement between ANI Pharmaceuticals Canada Inc. and Mastercom Inc (Filed With SEC on February 29, 2024)
- Agreement of Purchase and Sale between ANI Pharmaceuticals Canada, Inc. and 1540700 Ontario Limited (Filed With SEC on February 23, 2024)
- Asset Purchase Agreement between Holmdel Pharmaceuticals, LP and ANI Pharmaceuticals, Inc (Filed With SEC on May 10, 2022)
- Asset Purchase Agreement between Cranford Pharmaceuticals, LLC and ANI Pharmaceuticals, Inc (Filed With SEC on May 10, 2022)
- Asset Purchase Agreement between Amerigen Pharmaceuticals LTD. and ANI Pharmaceuticals, Inc (Filed With SEC on February 27, 2020)
- Amendment No. 4 to Asset Purchase Agreement between ANI Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc (Filed With SEC on May 9, 2019)
- Asset Purchase Agreement between AstraZeneca AB, AstraZeneca UK Limited, and ANI Pharmaceuticals, Inc (Filed With SEC on February 27, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 17, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 4, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 14, 2009)
- COMMONSTOCK PURCHASE AGREEMENT byand between KINGSBRIDGECAPITAL LIMITED and BIOSANTEPHARMACEUTICALS INC. datedas of December 15, 2008 (Filed With SEC on December 18, 2008)
